| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
| filingDate |
2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1436acd86385813c369f54c0cb19e623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da35f4b4303aae4dfc15407b0ce96c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fbf97abfda406904c3191ab1e0395b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b940946ee7a3f3384402f2492c7d55d |
| publicationDate |
2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2014009373-A |
| titleOfInvention |
USE OF LAQUINIMOD TO TREAT PATIENTS WITH CROHN'S DISEASE THAT FAILED IN THE FIRST LINE ANTI-TNFA THERAPY. |
| abstract |
This application provides a method for treating a human patient affected with anti-TNFa refractory Crohn's disease, for treating a human patient affected with non-fibrostenotic Crohn's disease, and for treating a human patient whose Crohn's disease had not been treated surgically, the method comprises periodically administering to the patient a quantity of laquinimod or pharmaceutically acceptable salt thereof effective to treat the patient. This application also provides a method to induce or maintain clinical remission in a human patient affected with Crohn's disease which comprises periodically administering to the patient an amount of effective laquinimod to induce or maintain clinical remission in the patient, whose amount of laquinimod is less than 0.5 mg / day. |
| priorityDate |
2012-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |